PPAR, RXR, and VDR Expressions in Diabetes
PPAR-γ, RXR, VDR, and NF-κB Expressions in Gingival Tissue Samples of Healthy
1 other identifier
observational
45
1 country
1
Brief Summary
Objective: Diabetes and periodontitis are two chronic inflammatory diseases sharing specific etiopathogenetic mechanisms, and both cause severe inflammation and destruction. The aim of the present study was to determine the receptor expressions of Peroxisome proliferative-activated receptor (PPAR)-γ, Retinoid X receptor (RXR)-α, Vitamin D receptor (VDR), and nuclear factor kappa B (NF-κB) expressions in healthy gingiva and diseased gingival samples with diabetes. Methods: 45 participants as 1; healthy controls (C), 2; periodontitis group (P), and 3; diabetes and periodontitis group (DP) were enrolled. Plaque index (PI), gingival index (GI) and clinical attachment levels (CAL) were recorded in all participants. Two gingival biopsies from each participant were obtained, and one underwent histological tissue processing while the other underwent RT-PCR analysis of nuclear receptors. Inflammatory and fibroblast cell counts, PPAR-γ, RXR-α, and VDR were evaluated. Results: Fibroblast cells were lowest in the DP group and highest in the healthy group. PPAR-γ, VDR, RXR, and NF-κB expressions were higher in the healthy controls in the RT-PCR analysis and similar in the other groups. Immunohistochemistry analysis also showed similar results. Conclusion: Results concluded that healthy gingival samples had higher PPAR-γ, RXR, VDR, and NF-κB expressions, and the immunohistochemistry results also supported this finding. The healthy gingiva contained higher fibroblast cells and lower inflammatory cells.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
January 27, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedJanuary 31, 2020
January 1, 2020
6 months
January 27, 2020
January 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
histological tissue evaluation
Inflammatory and fibroblast cell counts, PPAR-γ, RXR-α, and VDR were evaluated.
1 month.
Study Arms (3)
group (C)
healthy controls group
group (P)
periodontitis group
group (DP)
diabetes and periodontitis group
Interventions
Two gingival biopsies from each participant were collected.
Eligibility Criteria
Forty-two participants, 14 participants in each group, were enrolled in the study. The study groups were as follows. Healthy controls (C, mean age 41.05±1.80, seven men, seven women) Periodontitis patients with stage 3 grade B, (P, mean age 42.35±1.92, seven men, seven women) Patients with diabetes and periodontitis with stage 3 grade C, (DP, mean age 41.09±1.28, seven men, seven women)
You may qualify if:
- Periodontally healthy
You may not qualify if:
- Smokers
- Inflammatory state
- The existence of less than ten or over missing teeth
- drug use
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziosmanpasa University
Tokat Province, 60100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mehmet M Taskan, Phd,DDS
TOGU
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 27, 2020
First Posted
January 29, 2020
Study Start
January 1, 2019
Primary Completion
July 1, 2019
Study Completion
December 31, 2019
Last Updated
January 31, 2020
Record last verified: 2020-01
Data Sharing
- IPD Sharing
- Will not share